Zambian Vice-President Inonge Wina on Tuesday launched a new drugs manufacturing plant, saying it will go a long way in curbing drug shortages in the country.
The Zambian vice-president said during the launch of the 21 million U.S. dollars Yash Life Sciences pharmaceutical plant that the commissioning of the plant will result in the establishment of a robust and resilient supply chain of drugs.
“This development will significantly enhance the medical supply chain and reduce the price of essential drugs that will be manufactured locally,” she is quoted as saying by state-run news agency, the Zambia News and Information Service (ZANIS) during the commissioning of the plant in Kafue district, about 41 kilometers south of Lusaka, the country’s capital.
According to her, the development will further contribute to the provision of medical supply needs and government’s crusade to attain universal health coverage in the provision of access to essential medicines.
The manufacturing plant has also come with benefits of providing better available and affordable medicine as well as job creation for the people, she added.
Himanshu Patel, the firm’s director said his company was committed to ensuring a stable, healthy and sustainable society through the provision of essential drugs.
He further assured the government of good stock and management of essential medicines across the country, adding that the plant will make Zambia become a regional hub for essential medicines.
With an installed capacity to produce 330 million tablets, 90 million capsules and 1.2 million bottles per month, the plant is expected to create about 1,500 direct and indirect jobs and serve as a center for pharmaceutical training. Enditem